Cite

HARVARD Citation

    Ma, Z. et al. (2023). Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes. Journal of diabetes research. p. . [Online]. 
  
Back to record